Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 34% ± 17% | |
macrophage | 4 studies | 22% ± 8% | |
ciliated cell | 3 studies | 26% ± 6% |
Insufficient scRNA-seq data for expression of LYSET at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 539.51 | 180 / 180 | 100% | 13.81 | 430 / 430 |
prostate | 100% | 1042.96 | 245 / 245 | 100% | 28.19 | 502 / 502 |
skin | 100% | 518.03 | 1808 / 1809 | 100% | 21.85 | 472 / 472 |
lung | 100% | 757.78 | 578 / 578 | 100% | 12.07 | 1154 / 1155 |
brain | 100% | 454.00 | 2638 / 2642 | 100% | 11.52 | 705 / 705 |
uterus | 100% | 586.74 | 170 / 170 | 100% | 13.36 | 458 / 459 |
breast | 100% | 705.27 | 459 / 459 | 100% | 14.53 | 1113 / 1118 |
thymus | 100% | 746.39 | 653 / 653 | 100% | 12.47 | 602 / 605 |
kidney | 100% | 1010.89 | 89 / 89 | 99% | 11.20 | 896 / 901 |
esophagus | 100% | 573.80 | 1444 / 1445 | 99% | 9.51 | 182 / 183 |
pancreas | 100% | 458.18 | 327 / 328 | 99% | 11.44 | 177 / 178 |
stomach | 100% | 666.65 | 359 / 359 | 99% | 9.49 | 282 / 286 |
bladder | 100% | 681.90 | 21 / 21 | 98% | 11.41 | 496 / 504 |
intestine | 100% | 812.36 | 966 / 966 | 98% | 10.42 | 515 / 527 |
adrenal gland | 100% | 886.43 | 258 / 258 | 95% | 8.21 | 219 / 230 |
liver | 100% | 355.05 | 226 / 226 | 95% | 6.95 | 384 / 406 |
adipose | 100% | 653.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 22.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.67 | 29 / 29 |
spleen | 100% | 649.02 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.90 | 1 / 1 |
blood vessel | 100% | 588.29 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 703.57 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 587.99 | 852 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.42 | 44 / 45 |
peripheral blood | 91% | 342.93 | 843 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0060627 | Biological process | regulation of vesicle-mediated transport |
GO_0007041 | Biological process | lysosomal transport |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031985 | Cellular component | Golgi cisterna |
GO_0005515 | Molecular function | protein binding |
Gene name | LYSET |
Protein name | Lysosomal enzyme trafficking factor (GNPTAB cleavage and activity factor) (GCAF) (Transmembrane protein 251) |
Synonyms | TMEM251 C14orf109 |
Description | FUNCTION: Required for mannose-6-phosphate-dependent trafficking of lysosomal enzymes . LYSET bridges GlcNAc-1-phosphate transferase (GNPTAB), to the membrane-bound transcription factor site-1 protease (MBTPS1), thus allowing proteolytic activation of the GNPTAB. GNPTAB is involved in the regulation of M6P-dependent Golgi-to-lysosome trafficking of lysosomal enzymes . LYSET is thus an essential factor for maturation and delivery of lysosomal hydrolases . .; FUNCTION: (Microbial infection) Essential for infection by muliple viruses, including SARS-CoV-2, that utilize activated cathepsins for entry after M6P-dependent lysosomal transport. . |
Accessions | ENST00000283534.4 [Q8N6I4-2] Q8N6I4 ENST00000415050.3 [Q8N6I4-1] ENST00000626767.1 [Q8N6I4-2] ENST00000622205.2 [Q8N6I4-3] |